April 2007:
April 26th:
Rockeby Appoints Nucare Group Plc as UK Marketing and Distribution Partner for CanDia5 Rapid Candida Test
read article >
April 26th:
Pro Medicus Signs Major Digital Imaging Sale
read article >
April 17th:
Murdoch University Research Confirms Rockeby Rapid Bird Flu Tests Effectiveness
read article >
April 17th:
ChemGenex Reports Preclinical Data at American Association of Cancer
Research (AACR) Annual Conference
read article >
April 17th:
Bionomics Presents Cancer Data At Key International Cancer Conference
read article >
April 16th:
Progen's Phase 2 Liver Cancer Trial Exceeds Efficacy Objective
read article >
April 11th:
Cryptopharma Cystic Fibrosis inflammation Drug To Be Commercialised
read article >
April 11th:
Clinuvel Receives Approval To Begin Phase III Trials
read article >
April 10th:
US-based BrainZ Executive Richard Smith Appointed CEO
read article >
April 5th:
pSivida Provides Further Information on US$9 million Placement
read article >
April 4th:
pSivida And Sandell Agree To Redeem Entire Convertible Loan
read article >
April 4th:
pSivida signs A$203 million (US$165 million) Collaborative Research and Licensing Agreement with Pfizer
read article >
April 4th:
ChemGenex Announces Initiation of Second Phase 2/3 Clinical Trial for Ceflatonin® in CML
read article >
April 2nd:
Rockeby receives European Over-The-Counter Approval for CanDia5 Candida Rapid Test
read article >
|
